AI-Driven and Automated Continuous Oxygen Saturation Monitoring and LTOT: A Systematic Review

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Long-term oxygen therapy (LTOT) is essential for patients with chronic hypoxemia, particularly due to chronic obstructive pulmonary disease (COPD). However, conventional LTOT relies on static oxygen flow rates that fail to reflect patients’ fluctuating physiological demands. Emerging systems leveraging artificial intelligence (AI) and automation offer real-time SpO₂ monitoring and adaptive oxygen titration. This systematic review evaluates the performance, usability, and clinical readiness of such technologies in LTOT.

Methods

Following PRISMA 2020 guidelines, we searched PubMed, Web of Science, and Scopus (2000–2024) for English-language, peer-reviewed studies describing AI or automated SpO₂ systems in adults with LTOT relevance. Inclusion criteria focused on systems addressing motion artifacts, low-perfusion reliability, or skin tone bias. Extracted data included algorithm design, accuracy (e.g., MAE, RMSE), usability, and risk of bias.

Results

Eight studies met the inclusion criteria: five AI-based and three automated systems. AI models achieved high SpO₂ estimation accuracy (MAE as low as 0.57%) and addressed motion artifacts and demographic bias. Cabanas et al. 6 notably performed skin tone–stratified validation. Automated systems like O₂matic and iPOC demonstrated clinical efficacy in maintaining SpO₂ targets and reducing provider workload. However, AI models were mostly in prototype or simulation stages and lacked real-world LTOT validation. Risk of bias was moderate to high, especially in participant selection and algorithm transparency.

Conclusions

AI and automation offer distinct yet synergistic benefits for modernizing LTOT. Automated systems support immediate clinical use, while AI models hold promise for personalized, predictive oxygen therapy. Future work must prioritize real-world validation, equity, usability, and regulatory alignment to ensure ethical and effective integration into LTOT care.

Article activity feed